2026年1月30日, Ionis制药公司经理以160万美元出售了19,000多股股票。 
On January 30, 2026, Ionis Pharmaceuticals executives sold over 19,000 shares for $1.6 million.
2026年1月30日, Ionis制药公司经理Elizabeth Hougen、Eric Swayze和Brian Birchler各自出售公司股票股份,总股份总额超过19 000股,产生大约160万美元。 On January 30, 2026, Ionis Pharmaceuticals executives Elizabeth Hougen, Eric Swayze, and Brian Birchler each sold shares of company stock, collectively totaling over 19,000 shares and generating approximately $1.6 million. 向证交会报告的这些交易减少了个人持有量,Hougen出售6 988份股票,价值83.24美元,Swayze 6 179美元,价值82.93美元,Birchler 6 179美元,价值83.03美元。 The transactions, reported to the SEC, reduced their individual holdings, with Hougen selling 6,988 shares at $83.24, Swayze 6,179 at $82.93, and Birchler 6,179 at $83.03. 该股票于2026年2月3日以83.07美元关闭,市场上限为134.5亿美元,并被评为“Moderate Buy”分析师评级。 The stock closed at $83.07 on February 3, 2026, with a market cap of $13.45 billion and a "Moderate Buy" analyst rating.
